tiprankstipranks
Trending News
More News >
Amerant Bancorp Inc Class A (AMTB)
NYSE:AMTB

Amerant Bancorp (AMTB) AI Stock Analysis

Compare
61 Followers

Top Page

AMTB

Amerant Bancorp

(NYSE:AMTB)

Select Model
Select Model
Select Model
Neutral 69 (OpenAI - 5.2)
Rating:69Neutral
Price Target:
$23.50
▲(8.29% Upside)
The score is supported primarily by improved financial statement trends (profitability recovery and strong free-cash-flow conversion) and constructive technical momentum (price above key moving averages, positive MACD). These positives are tempered by the earnings-call signals of significant near-term operational and credit headwinds (EPS decline, large non-core expense items, and higher nonperforming assets), while valuation is reasonable but not sufficiently cheap to offset the near-term risks.
Positive Factors
Cash generation and revenue recovery
Sustained TTM revenue growth and robust free cash flow growth indicate the franchise is converting earnings into liquidity. Durable FCF (97% FCF-to-net-income) supports reinvestment, provisioning and capital returns, giving the bank flexibility to execute its turnaround without immediate external financing.
Capital buffer and capital actions
A CET1 ratio at 11.8% combined with authorized repurchases and an ongoing dividend signals meaningful regulatory capital headroom and management confidence. This capital flexibility helps absorb loan losses, enables balance-sheet optimization and supports shareholder returns while the bank executes remediation.
Comprehensive credit remediation effort
A deep, bank-wide review covering ~85% of commercial commitments and intensive special-assets work is a structural fix to underwriting and risk governance. Though near-term costs rise, improving risk-selection, accelerated resolutions and loan sales should lower future credit volatility and strengthen portfolio quality over multiple quarters.
Negative Factors
Rising nonperforming assets
NPLs rising to $187M (1.9% of assets) reflects material credit stress in commercial portfolios. Elevated problem assets require higher provisioning and potential charge-offs, eroding earnings and capital cushions and constraining future lending capacity until remediation and sales materially reduce classified balances.
High operating costs and non-core charges
A spike in noninterest expense and a reported efficiency ratio near 95% (even with a core ratio >72%) indicates structural cost pressures and one-off impairments. Persistent elevated operating leverage and recurring non-core items will hinder sustainable ROA and ROE improvements unless structural expense reduction plans are realized.
Balance-sheet contraction and deposit outflows
Quarterly declines in deposits and loans shrink the funding base and earning asset scale, reducing net interest income potential. If contraction persists, the bank may face tighter liquidity/funding costs or slower loan-originations, limiting margin recovery and the ability to achieve medium-term loan growth targets.

Amerant Bancorp (AMTB) vs. SPDR S&P 500 ETF (SPY)

Amerant Bancorp Business Overview & Revenue Model

Company DescriptionAmerant Bancorp Inc. operates as the bank holding company for Amerant Bank, N.A. that provides banking products and services to individuals and businesses in the United States and internationally. The company offers checking, savings, and money market accounts; and certificates of deposits. It also provides variable and fixed rate commercial real estate loans; loans secured by owner-occupied properties; loans to domestic and foreign individuals primarily secured by personal residence; working capital loans, asset-based lending, participations in shared national credits, purchased receivables, and small business administration loans; loans to financial institutions and acceptances; and consumer loans and overdrafts, such as automobile, personal, or loans secured by cash or securities and revolving credit card agreements. In addition, the company offers trust and estate planning products and services to high-net-worth customers, brokerage and investment advisory services in global capital markets, and wealth management and fiduciary services. Further, it provides debit and credit cards, night depositories, direct deposits, cashier's checks, safe deposit boxes, letters of credit, and treasury management services, including wire transfer, remote deposit capture, and automated clearinghouse services; derivative instruments; and online and mobile banking, account balances, statements and other documents, online transfers and bill payment, and electronic delivery of customer statements services, as well as automated teller machines, and banking by mobile devices, telephone, and mail. As of December 31, 2021, the company operated 24 banking centers comprising 17 in Florida and 7 in Texas. It also operates loan production offices in Tampa, Florida. The company was formerly known as Mercantil Bank Holding Corporation and changed its name to Amerant Bancorp Inc. in June 2019. Amerant Bancorp Inc. was founded in 1979 and is headquartered in Coral Gables, Florida.
How the Company Makes MoneyAmerant Bancorp generates revenue through several key streams. The primary source is net interest income, which is earned from the interest on loans provided to customers and the interest from securities held by the bank, offset by interest expenses related to deposits and borrowings. Additionally, the company earns non-interest income from various fees associated with banking services, such as account maintenance fees, transaction fees, and wealth management services. Significant partnerships and relationships with commercial clients also contribute to its earnings, especially through business lending and treasury management services. Overall, the company’s diversified approach allows it to leverage different revenue streams to enhance profitability.

Amerant Bancorp Earnings Call Summary

Earnings Call Date:Jan 23, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Apr 29, 2026
Earnings Call Sentiment Negative
The call outlined a clear strategic roadmap (3-year plan), capital actions (buybacks and dividend), targeted cost reductions and balance sheet optimization, and some favorable items such as AUM growth and lower provisions this quarter. However, the quarter was marked by materially weaker profitability (EPS collapse), sharply higher reported expenses and large non-core charges, contraction of assets, deposits and loans, a significant drop in pre-provision net revenue, and increased nonperforming assets. Management provided near-term expense and margin guidance and aspirational medium-term targets (ROA ~1%, efficiency ~60%), but the current operating results and asset-quality work create meaningful short-term headwinds. Overall, the negative financial developments and asset-quality/expense pressures materially outweigh the strategic progress and select positive items communicated on the call.
Q4-2025 Updates
Positive Updates
Board Approval of 3-Year Strategic Plan
Board approved a disciplined 3-year strategic plan focused on stabilizing, optimizing and growing the franchise, with priorities on credit transformation, balance sheet optimization, operational efficiency and targeted investments (including AI) to improve productivity and client experience.
Share Repurchase Program and Dividend Continuation
Board approved continued capital return: repurchased 737,334 shares at a weighted average price of $17.63 (repurchase activity of ~$13.0M referenced) and declared/payed quarterly common dividend of $0.09 per share (paid Nov 28, 2025; next payable Feb 27, 2026).
Capital and CET1 Stability
Common equity tier 1 (CET1) rose to 11.8% from 11.54% quarter-over-quarter, driven by lower risk-weighted assets and net income (partially offset by repurchases/dividends), indicating maintained regulatory capital headroom.
Assets Under Management Growth
Assets under management increased $87.2 million to $3.3 billion in 4Q'25, driven by higher market valuations and net new assets, supporting fee-income growth opportunities.
Noninterest Income Improved QoQ
Noninterest income rose to $22.0 million in 4Q'25 from $17.3 million in 3Q'25 (increase of $4.7M), aided by gains on sale-leaseback transactions and higher gains from securities sales.
Provision for Credit Losses Declined
Provision for credit losses decreased to $3.5 million in 4Q'25 from $14.6 million in 3Q'25 (down $11.1M), reflecting releases and lower net change in specific reserves.
Balance Sheet Optimization Actions
Management reduced wholesale funding and higher-cost deposits, repaid $119.7 million of long-term FHLB advances and intentionally reduced total assets below the $10 billion watermark to right-size the balance sheet.
Clear near-term financial targets and cost guidance
Management set near-term targets: 2026 aspirational ROA around 1% and efficiency ratio near 60% (longer-term target to approach peer levels), expense guidance of ~$70–71M in 1H26 progressing to $67–68M by year-end, and loan growth guidance of 7%–9% for 2026 with NIM projected at 3.65%–3.70%.
Negative Updates
Significant Decline in Net Income and EPS
Diluted earnings per share fell to $0.07 in 4Q'25 from $0.35 in 3Q'25 (down ~$0.28 or ~80%), driven by lower net income and higher noninterest expenses.
Sharp Increase in Expenses and Deterioration of Efficiency Ratio
Total noninterest expense rose to $106.8 million in 4Q'25, up $28.9 million QoQ; reported efficiency ratio deteriorated to 95.19% from 69.84% the prior quarter (core efficiency ratio 72.58% excluding non-core items).
Large Non-Core Charges
Non-core noninterest expenses of $29.2 million included $14.9M losses on loans held for sale (including $13.8M year-end valuation allowance), $7.5M contract termination costs, $3.8M separation costs, $2.5M investment impairment and $0.5M intangible impairment tied to mortgage wind-down.
Material QoQ Declines in Balance Sheet Size and Liquidity
Total assets decreased to $9.8 billion from $10.4 billion in 3Q'25 (down $600M, ~-5.8% QoQ); cash and cash equivalents fell $160.7M to $470.2M and total investments declined to $2.1B from $2.3B.
Deposits and Loans Contracted
Total deposits decreased $514M (6.2% QoQ) to $7.8B; total loans decreased $244.6M (3.5% QoQ) to $6.7B as prepayments/payoffs and credit-quality-focused run-off outpaced production.
Net Interest Income and Margin Pressures
Net interest income declined to $90.2M from $94.2M (down $4.0M QoQ) and net interest margin compressed to 3.78% from 3.92% due to smaller balance sheet and timing of repricing after rate cuts.
Deterioration in Return Metrics
Reported return on assets (ROA) fell to 0.10% from 0.57% QoQ and return on equity (ROE) dropped to 1.12% from 6.21%, reflecting lower profitability and elevated expenses.
Pre-Provision Net Revenue Collapse
Pre-provision net revenue (PPNR) decreased dramatically to $5.4M in 4Q'25 from $33.6M in 3Q'25 (an ~84% decline); core PPNR declined to $29.3M from $35.8M QoQ, driven by higher non-core expenses.
Asset Quality Worsened on a Reported Basis
Nonperforming assets increased to $187M (1.9% of total assets) from $140M (1.3%) the prior quarter; gross charge-offs totaled $29.5M in 4Q'25 and allowance-for-credit-losses coverage ratio decreased to 1.20% from 1.37% QoQ.
Ongoing Credit Remediation Required
Large-scale credit review (covering ~$5.3B or ~85% of commercial loans) triggered migrations into criticized/nonperforming categories primarily in CRE and commercial Florida/Texas portfolios; management expects continued exits, sales and resolutions but near-term asset-quality headwinds remain.
Company Guidance
Management guided that loan balances in 1Q'26 should be roughly flat to 4Q'25 while full‑year 2026 loan growth is targeted at 7%–9% (with deposit growth expected to match), net interest margin is projected at 3.65%–3.70%, and quarterly expenses are expected to run about $70–71 million in the first half of 2026, progressively declining to a normalized $67–68 million by year‑end; they also reiterated continued capital actions (share repurchases and a $0.09 quarterly dividend) and longer‑term strategic targets of roughly 1.0% ROA and a ~60% efficiency ratio for 2026, with the aspiration to push efficiency into the mid‑50s and ROA above 1% in 2027–28, and noted expected credit/portfolio improvements (criticized‑bucket outflows > inflows) with provisioning run‑rate commentary around ~40–45 bps.

Amerant Bancorp Financial Statement Overview

Summary
Income statement trends are improving (TTM revenue growth 11.1% and net profit margin 10.8% after a prior-year loss), and cash generation looks solid (TTM free cash flow growth 13.8% with FCF-to-net-income at 97.2%). The key offset is balance-sheet risk: leverage is moderate (debt-to-equity 1.10) and the equity ratio is described as relatively low, which raises sensitivity to credit and funding conditions.
Income Statement
75
Positive
Amerant Bancorp's income statement shows a strong recovery with a TTM revenue growth rate of 11.1% and a net profit margin of 10.8%. The company has improved its profitability significantly from the previous year, moving from a negative net profit margin to a positive one. However, the gross profit margin has decreased slightly, indicating potential cost pressures. Overall, the income statement reflects a positive growth trajectory and improved profitability.
Balance Sheet
68
Positive
The balance sheet of Amerant Bancorp indicates a moderate level of leverage with a debt-to-equity ratio of 1.10. The return on equity has improved to 7.7%, showcasing better utilization of equity. However, the equity ratio is relatively low, suggesting a higher reliance on debt financing. The company has made progress in strengthening its equity position, but the leverage remains a potential risk.
Cash Flow
72
Positive
Amerant Bancorp's cash flow statement highlights a robust free cash flow growth of 13.8% in the TTM period. The free cash flow to net income ratio is strong at 97.2%, indicating efficient cash generation relative to net income. However, the operating cash flow to net income ratio is not available, which limits a full assessment of operational cash flow efficiency. Overall, the cash flow position is solid with significant improvements in free cash flow.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue655.25M574.92M551.02M387.07M307.75M333.77M
Gross Profit375.91M244.83M267.63M301.01M281.55M174.15M
EBITDA70.77M-17.48M48.17M84.47M151.29M5.05M
Net Income52.42M-15.75M32.49M63.31M112.92M-1.72M
Balance Sheet
Total Assets9.78B9.90B9.72B9.13B7.64B7.77B
Cash, Cash Equivalents and Short-Term Investments2.50B2.00B1.51B1.31B1.45B1.44B
Total Debt0.001.00B921.33M1.20B1.07B1.17B
Total Liabilities8.84B9.01B8.98B8.42B6.81B6.99B
Stockholders Equity938.80M890.47M736.07M707.82M834.48M783.42M
Cash Flow
Free Cash Flow97.96M74.79M15.79M-59.79M60.85M51.67M
Operating Cash Flow100.50M82.19M26.72M-49.16M67.43M57.25M
Investing Cash Flow-501.10M-576.66M-606.62M-1.40B385.32M286.34M
Financing Cash Flow441.10M762.96M611.17M1.46B-392.93M-250.52M

Amerant Bancorp Technical Analysis

Technical Analysis Sentiment
Positive
Last Price21.70
Price Trends
50DMA
19.98
Positive
100DMA
19.31
Positive
200DMA
18.95
Positive
Market Momentum
MACD
0.43
Negative
RSI
60.32
Neutral
STOCH
49.27
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AMTB, the sentiment is Positive. The current price of 21.7 is above the 20-day moving average (MA) of 20.78, above the 50-day MA of 19.98, and above the 200-day MA of 18.95, indicating a bullish trend. The MACD of 0.43 indicates Negative momentum. The RSI at 60.32 is Neutral, neither overbought nor oversold. The STOCH value of 49.27 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AMTB.

Amerant Bancorp Risk Analysis

Amerant Bancorp disclosed 52 risk factors in its most recent earnings report. Amerant Bancorp reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Amerant Bancorp Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
$1.16B11.3913.88%1.70%4.33%-2.20%
76
Outperform
$919.27M11.1219.62%0.04%33.22%38.44%
74
Outperform
$956.87M12.966.53%4.73%6.27%79.25%
70
Outperform
$967.83M14.068.53%4.59%-4.08%-16.80%
70
Outperform
$943.69M10.599.61%2.59%4.49%20.44%
69
Neutral
$895.46M17.287.21%1.79%15.37%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AMTB
Amerant Bancorp
21.70
-0.51
-2.30%
CFFN
Capitol Federal Financial
7.28
1.70
30.49%
NBN
Northeast Bancorp
115.23
15.57
15.62%
SBSI
Southside Bancshares
32.19
2.77
9.42%
UVSP
Univest Of Pennsylvania
33.14
4.11
14.16%
AMAL
Amalgamated Bank
38.84
5.70
17.19%

Amerant Bancorp Corporate Events

Business Operations and StrategyStock BuybackDividendsFinancial Disclosures
Amerant Bancorp posts Q4 profit, unveils buyback plan
Neutral
Jan 22, 2026

On January 22, 2026, Amerant Bancorp reported fourth-quarter 2025 net income of $2.7 million, or $0.07 per diluted share, sharply lower than the prior quarter, as the bank absorbed higher non-interest expenses and ongoing credit normalization tied to strategic actions to improve risk selection and operational efficiency. For full-year 2025, however, Amerant swung to a net profit of $52.4 million, or $1.26 per diluted share, from a $15.8 million loss in 2024, supported by stronger net interest income, improved net interest margin and higher pre-provision net revenue, even as non-performing assets and classified loans rose and the allowance for credit losses decreased. The board declared a $0.09 per share dividend payable February 27, 2026, and approved a new Class A share repurchase program of up to $40 million through December 31, 2026, signaling confidence in the company’s capital position and long-term strategy despite near-term pressure on asset quality and profitability metrics such as efficiency ratio, ROA and ROE.

The most recent analyst rating on (AMTB) stock is a Hold with a $22.00 price target. To see the full list of analyst forecasts on Amerant Bancorp stock, see the AMTB Stock Forecast page.

Business Operations and StrategyM&A Transactions
Amerant Bancorp Completes Loan Sale to Peachtree Group
Neutral
Jan 7, 2026

On December 31, 2025, Amerant Bank, N.A., a subsidiary of Amerant Bancorp Inc., entered into an asset sale agreement with Peachtree Group to sell up to five loans with an estimated outstanding principal balance of $74 million. The transaction, which included customary representations, warranties, covenants and closing conditions, closed on January 7, 2026, with the bank ultimately selling three of the five loans to Peachtree for approximately $49.7 million after the purchaser chose not to acquire the remaining two loans, thereby reducing Amerant’s loan exposure and adjusting the composition of its loan portfolio.

The most recent analyst rating on (AMTB) stock is a Buy with a $23.00 price target. To see the full list of analyst forecasts on Amerant Bancorp stock, see the AMTB Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
Amerant Bancorp Issues Year-End 2025 Credit Risk Update
Negative
Dec 31, 2025

On December 30, 2025, Amerant Bancorp released an investor credit update detailing intensified efforts in the fourth quarter of 2025 to reinforce credit discipline and strengthen credit risk management ahead of year-end. During 2025, the bank’s Credit Administration and Credit Review functions, including a third-party firm, reassessed risk ratings across about 85% of its commercial and CRE loan commitments, with roughly $4.5 billion, or 73%, reviewed through financial statement and covenant analysis in the fourth quarter alone. Management increased oversight through weekly leadership meetings focused on special assets, added resources to accelerate portfolio reviews, and expanded coverage to validate risk ratings, while the Special Assets group pushed resolutions of criticized credits through loan sales and heightened collection efforts on previously charged-off loans. As part of criticized portfolio management, the company moved approximately $94 million of loans from held for investment to held for sale, recognizing a non-routine loss of about $16 million but positioning itself to reduce classified loans by $94 million upon expected sale closings in January 2026. The update showed that estimated non-performing loans rose to about $156.7 million in the fourth quarter of 2025, driven primarily by five loans placed on non-accrual status, with subsequent transfers of $19 million in non-accrual loans to held for sale expected to lower NPLs to around $137 million, while charge-offs of $23 million were partly offset by approximately $18 million in recoveries and previously recorded specific reserves. Special mention and classified loans saw active churn through downgrades, paydowns, charge-offs and loan sales, with a significant portion secured by real estate at relatively conservative loan-to-value ratios, underscoring Amerant’s attempt to clean up problem assets and bolster its balance sheet despite near-term credit costs.

The most recent analyst rating on (AMTB) stock is a Buy with a $22.00 price target. To see the full list of analyst forecasts on Amerant Bancorp stock, see the AMTB Stock Forecast page.

Business Operations and StrategyM&A Transactions
Amerant Bancorp Highlights Strategic Focus in Florida
Positive
Nov 10, 2025

On November 11, 2025, Amerant Bancorp presented a slide presentation to existing and prospective investors, highlighting its strategic focus on organic growth in Florida following the sale of its Houston franchise. The company has completed a core conversion to a new tech system, enhancing customer service and operational efficiency, and continues to invest in business development and risk management to drive growth.

The most recent analyst rating on (AMTB) stock is a Hold with a $20.00 price target. To see the full list of analyst forecasts on Amerant Bancorp stock, see the AMTB Stock Forecast page.

Business Operations and StrategyExecutive/Board Changes
Amerant Bancorp Appoints Interim CEO Amid Leadership Change
Neutral
Nov 6, 2025

On November 4, 2025, Amerant Bancorp announced the mutual agreement for Jerry Plush to step down as President and CEO, effective November 5, 2025. Carlos Iafigliola, previously the Senior Executive Vice President and Chief Operating Officer, has been appointed as the Interim CEO. The transition is part of Amerant’s ongoing efforts to advance its growth strategy and improve operational efficiency. The Board, led by newly appointed Chair Odilon Almeida Jr., will conduct a search for a permanent CEO. The leadership change is not related to any disagreements or compliance issues, and the Board is confident in Iafigliola’s ability to lead the company through its next phase of growth.

The most recent analyst rating on (AMTB) stock is a Hold with a $20.00 price target. To see the full list of analyst forecasts on Amerant Bancorp stock, see the AMTB Stock Forecast page.

Business Operations and StrategyStock BuybackDividendsFinancial Disclosures
Amerant Bancorp Reports Q3 2025 Earnings Decline
Negative
Oct 28, 2025

On October 28, 2025, Amerant Bancorp reported a net income of $14.8 million for the third quarter of 2025, a decrease from the previous quarter’s $23.0 million. The company is focusing on reducing non-performing loans and plans to resume share buybacks and implement expense reductions to improve results. Total assets increased slightly to $10.4 billion, while total gross loans decreased to $6.9 billion. The company declared a cash dividend of $0.09 per share, payable on November 28, 2025.

The most recent analyst rating on (AMTB) stock is a Buy with a $26.00 price target. To see the full list of analyst forecasts on Amerant Bancorp stock, see the AMTB Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 26, 2026